p38γ MAPK is required for inflammation-associated colon tumorigenesis

Area of Science:

• Oncology
• Molecular Biology
• Inflammation Research

Background:

• Chronic inflammation is a known risk factor for colon cancer.
• The specific molecular mechanisms linking inflammation to colon cancer remain unclear.
• Signal transduction pathways mediating this link are largely unidentified.

Purpose of the Study:

• To investigate the role of p38γ mitogen-activated protein kinase in inflammation-driven colon tumorigenesis.
• To identify p38γ as a key mediator of inflammatory signaling in colon cancer.
• To evaluate p38γ as a potential therapeutic target for colon cancer.

Main Methods:

• Utilized mouse models with intestinal epithelial cell-specific p38γ knockout (KO).
• Administered pirfenidone, a p38γ pharmacological inhibitor, in a colitis-associated mouse model.
• Performed xenograft studies to assess tumor-promoting activity.
• Investigated the interaction between p38γ and β-catenin/Wnt signaling.

Main Results:

• p38γ activation was observed in mouse colon tissues during inflammation.
• p38γ KO attenuated colitis and reduced pro-inflammatory cytokine expression.
• p38γ KO significantly inhibited tumorigenesis in a colitis-associated cancer model.
• Pirfenidone suppressed inflammation and colon tumor growth.
• p38γ was found to be essential for β-catenin/Wnt pathway activation, phosphorylating β-catenin at Ser605 to stimulate Wnt transcription.

Conclusions:

• p38γ mitogen-activated protein kinase acts as a crucial link between chronic inflammation and colon tumorigenesis.
• Targeting p38γ demonstrates potential as a novel strategy for colon cancer prevention and treatment.
• Understanding the p38γ-mediated signaling pathway provides new insights into colon cancer development.